PELVIC IMRT WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH RISK (SCORE NCCN) PROSTATE CANCER

被引：0
|
作者：
Magli, A. [1 ]
Malisan, M. R. [2 ]
Foti, C. [2 ]
Moretti, E. [2 ]
Marino, M. [3 ]
Prisco, A. [1 ]
Polsinelli, M. [1 ]
Signor, M. [1 ]
Fongione, S. [4 ]
机构：
[1] AOU SMM Udine, Dept Radiotherapy, Udine, Italy
[2] AOU SMM Udine, Div Med Phys, Udine, Italy
[3] AOU SMM Udine, Dept Gastrointestinal Surg, Udine, Italy
[4] AOU SMM Udine, Dept Radiol, Udine, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1220
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [1] PELVIC IMRT AND HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH-RISK PROSTATE CANCER
    Alessandro, Magli
    De Giorgi, Gioacchino
    Ceschia, Tino
    Crivellaro, Simone
    Marino, Marco
    Parisi, Giuseppe
    Signor, Marco
    Titone, Francesca
    Frea, Bruno
    Fongione, Sandro
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1876 - 1877
  • [2] Hypofractionated Simultaneous Integrated Boost IMRT in high risk prostate cancer - A novel approach
    Sashidharan, S.
    Beena, K.
    Chelakkot, P. G.
    Madhavan, R.
    Menon, D.
    Makuny, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S636 - S636
  • [3] Early Experience of Simultaneous Integrated Boost IMRT to the Prostate and Pelvic Nodes for High Risk Prostate Cancer
    Anand, G.
    Dunn, P.
    Moorfoot, P.
    Jones, E.
    Davies, G.
    Taylor, A.
    Falconer, A.
    Mangar, S.
    [J]. CLINICAL ONCOLOGY, 2009, 21 (03) : 245 - 245
  • [4] Acute toxicity of hypofractionated IMRT with simultaneous integrated boost in high-risk prostate cancer patients
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    Souhami, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S689 - S689
  • [5] IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, X
    Wang, JZ
    Jursinic, P
    Lawton, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S632 - S633
  • [6] Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S364 - S364
  • [7] Whole Pelvic Radiotherapy With Hypofractionated Simultaneous Integrated Boost And Hormonal Therapy For NCCN High Risk Prostate Adenocarcinoma: Implications For The Alpha/Beta Ratio
    McDonald, A. M.
    Dobelbower, M. C.
    Jacob, R.
    Kim, R. Y.
    Wu, X.
    Fiveash, J. B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S416 - S417
  • [8] A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer
    Ishii, K.
    Ogino, R.
    Okada, W.
    Nakahara, R.
    Kawamorita, R.
    Nakajima, T.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2013, 86 (1030):
  • [9] Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, XA
    Wang, JZ
    Jursinic, PA
    Lawton, CA
    Wang, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1251 - 1257
  • [10] Efficacy of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to the prostate for intermediate-and high-risk prostate cancer
    Reddy, Krishna
    Strom, Tobin
    Plimpton, Reed
    Kavanagh, Brian D.
    Petersen, Jane
    Wilson, Shandra
    Maroni, Paul
    Raben, David
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 401 - 407
12345